Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Harrison

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Identification and Structure-Guided Development of Pyrimidinone Based USP7 InhibitorsColin R O'Dowd, Matthew D Helm, J S Shane Rountree, et al.
Cell Death & Disease|October 30, 2020
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancerHajrah Khawaja, Andrew Campbell, Jamie Z Roberts, et al.
Joint Commission Journal on Quality and Patient Safety|June 12, 2025
Effects of a Workplace Well-Being Program on Professional Quality of Life Among Health Care PersonnelNicholas A Giordano, Ingrid M Duva, Beth Ann Swan, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
ACS Chemical Biology|November 14, 2017
Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme SubfamilyJonathan D Wrigley, Gerald Gavory, Iain Simpson, et al.
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitorsIan Churcher, Dirk Beher, Jonathan D Best, et al.
Cancer|December 24, 2015
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramMark Lawler, Anna Gavin, Manuel Salto-Tellez, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Identification and Structure-Guided Development of Pyrimidinone Based USP7 InhibitorsColin R O'Dowd, Matthew D Helm, J S Shane Rountree, et al.
Cell Death & Disease|October 30, 2020
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancerHajrah Khawaja, Andrew Campbell, Jamie Z Roberts, et al.
Joint Commission Journal on Quality and Patient Safety|June 12, 2025
Effects of a Workplace Well-Being Program on Professional Quality of Life Among Health Care PersonnelNicholas A Giordano, Ingrid M Duva, Beth Ann Swan, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
ACS Chemical Biology|November 14, 2017
Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme SubfamilyJonathan D Wrigley, Gerald Gavory, Iain Simpson, et al.
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitorsIan Churcher, Dirk Beher, Jonathan D Best, et al.
Cancer|December 24, 2015
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramMark Lawler, Anna Gavin, Manuel Salto-Tellez, et al.
Pageof 8